A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor

Neurology

Volumn 76, Issue 5, 2011, Pages 451-455

  Pomper, J K ^a   Wilhelm, H ^b   Tayebati, S K ^c   Asmus, F ^a   Schule R ^a   Sievert, K D ^d   Haensch, C A ^e   Melms, A ^a   Haarmeier, T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c University of Witten/Herdecke ^*  (Italy)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BODY WEIGHT; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL MOTILITY; GENETIC SCREENING; HUMAN; KNOCKOUT MOUSE; LACRIMATION; MALE; MICTURITION DISORDER; MOUSE; MUSCARINIC M3 RECEPTOR DEFICIENCY; MYDRIASIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SALIVATION; SINGLE NUCLEOTIDE POLYMORPHISM; SWEATING; WESTERN BLOTTING;

EID: 79951470150     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820a0a75     Document Type: Article

References (25)

1. Steinlein OK. Genetic disorders caused by mutated acetyl-choline receptors. Life Sci 2007;80:2186-2190. (Pubitemid 46818288)
2. Richardson CE, Morgan JM, Jasani B, et al. Megacystis-microcolon- intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor sub-unit. Gastroenterology 2001;121:350-357. (Pubitemid 32729382)
3. Tayebati SK, El-Assouad D, Ricci A, Amenta F. Immuno-chemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol 2002;132:147-155. (Pubitemid 35333337)
4. Tayebati SK, Codini M, Gallai V, et al. Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 1999;99:224-229. (Pubitemid 29518235)
5. Tayebati SK, Amenta F, Amici S, et al. Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? J Neuroimmunol 2001;121:126-131. (Pubitemid 34008460)
6. Forsythe SM, Kogut PC, McConville JF, et al. Structure and transcription of the human m3 muscarinic receptor gene. Am J Respir Cell Mol Biol 2002;26:298-305. (Pubitemid 34170056)
7. Asmus F, Salih F, Hjermind LE, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol 2005;58:792-797. (Pubitemid 41552558)
8. Bremner FD, Smith SE. Pupil abnormalities in selected autonomic neuropathies. J Neuroophthalmol 2006;26: 209-219. (Pubitemid 44394294)
9. Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 2003; 53:752-758. (Pubitemid 36622512)
10. Abrams P, Andersson KE, Buccafusco JJ, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 2006;148:565-578. (Pubitemid 43993048)
11. Chess-Williams R, Chapple CR, Yamanishi T, Yasuda K, Sellers DJ. The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol 2001;21:243-248.
12. Woldemussie E, Feldmann BJ, Chen J. Characterization of muscarinic receptors in cultured human iris sphincter and ciliary smooth muscle cells. Exp Eye Res 1993;56:385-392. (Pubitemid 23176603)
13. Nietgen GW, Schmidt J, Hesse L, Honemann CW, Dur-ieux ME. Muscarinic receptor functioning and distribution in the eye: molecular basis and implications for clinical diagnosis and therapy. Eye 1999;13:285-300. (Pubitemid 29338859)
14. Choppin A, Eglen RM. Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle. Br J Pharmacol 2001;132:835-842. (Pubitemid 32193640)
15. Zinner N, Tuttle J, Marks L. Efficacy and tolerability of dar-ifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder. World J Urol 2005;23:248-252.
16. Matsui M, Motomura D, Karasawa H, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 2000;97:9579-9584. (Pubitemid 30650818)
17. Yamada M, Miyakawa T, Duttaroy A, et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001;410:207-212. (Pubitemid 32216592)
18. Low PA, Opfer-Gehrking TL, Kihara M. In vivo studies on receptor pharmacology of the human eccrine sweat gland. Clin Auton Res 1992;2:29-34.
19. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-580. (Pubitemid 14239727)
20. Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human musca-rinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand J Immunol 2004;59:261-266. (Pubitemid 38429292)
21. Losen M, Martinez-Martinez P, Phernambucq M, Schuur-man J, Parren PW, De Baets MH. Treatment of myasthe-nia gravis by preventing acetylcholine receptor modulation. Ann NY Acad Sci 2008;1132:174-179. (Pubitemid 351841374)
22. Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005;128:2518-2534. (Pubitemid 41552938)
23. Igawa Y, Zhang X, Nishizawa O, et al. Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J Urol 2004;172:2460-2464. (Pubitemid 39507553)
24. Bymaster FP, Carter PA, Yamada M, et al. Role of specific muscarinic receptor subtypes in cholinergic parasympatho-mimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 2003;17:1403-1410. (Pubitemid 36560839)
25. Stengel PW, Yamada M, Wess J, Cohen ML. M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 2002;282:R1443-R1449. (Pubitemid 34664532)